Orphan Drugs Market to Reach USD 340.84 Billion by 2027; Increasing Incidence of Life-threatening Diseases will Bode well for Market Growth, says Fortune Business Insights™

NEXT STORY
ABOG Appoints New Board of Directors Officer and Members, Division Chair, and Members of Subspecialty Divisions
PREV STORY
Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Horizon Pharma plc Announces Health Canada Approval of PROCYSBI™ (Cysteamine Delayed-Release Capsules) for the Treatment of Nephropathic Cystinosis

DUBLIN, Ireland, June 19, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Investor Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS)

author_avatar
NASDAQ Market News

NEOVACS Obtains South Korea Health Authority Approval for IND Application With IFNa Kinoid in Lupus

PARIS, April 14, 2016 (GLOBE NEWSWIRE) -- NEOVACS (Alternext Paris:ALNEV), a leader in active ...

author_avatar
NASDAQ Market News